Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates
Authors:
Open Access
- 11 March 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-19
Abstract
COVID-19 outbreak caused by SARS-CoV-2 created an unprecedented health crisis since there is no vaccine for this novel virus. Therefore, SARS-CoV-2 vaccines have become crucial for reducing morbidity and mortality. In this study, in vitro and in vivo safety and efficacy analyzes of lyophilized vaccine candidates inactivated by gamma-irradiation were performed. The candidate vaccines in this study were OZG-3861 version 1 (V1), an inactivated SARS-CoV-2 virus vaccine, and SK-01 version 1 (V1), a GM-CSF adjuvant added vaccine. The candidate vaccines were applied intradermally to BALB/c mice to assess toxicity and immunogenicity. Preliminary results in vaccinated mice are reported in this study. Especially, the vaccine models containing GM-CSF caused significant antibody production with neutralization capacity in absence of the antibody-dependent enhancement feature, when considered in terms of T and B cell responses. Another important finding was that the presence of adjuvant was more important in T cell in comparison with B cell response. Vaccinated mice showed T cell response upon restimulation with whole inactivated SARS-CoV-2 or peptide pool. This study shows that the vaccines are effective and leads us to start the challenge test to investigate the gamma-irradiated inactivated vaccine candidates for infective SARS-CoV-2 virus in humanized ACE2 + mice.Keywords
Funding Information
- Acibadem Healthcare Group
- TÜBİTAK 2247-C Trainee Researcher Scholarship Program
- TUBITAK-BIDEB 2244-University-Industry PhD program (118C082, 118C082)
This publication has 33 references indexed in Scilit:
- Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like ProteaseJournal of Virology, 2011
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon ChallengeJournal of Virology, 2011
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune ResponseJournal of Virology, 2011
- Intradermal delivery of vaccines: potential benefits and current challengesBulletin of the World Health Organization, 2011
- Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cellsNature Reviews Immunology, 2008
- Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?Vaccine, 2008
- Proposal for vaccination against SARS coronavirus using avian infectious bronchitis virus strain H from The NetherlandsJournal of Infection, 2005
- Intradermal Granulocyte–Macrophage Colony-Stimulating Factor Alters Cutaneous Antigen-Presenting Cells and Differentially Affects Local versus Distant Immunization in HumansClinical Immunology, 2000
- Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccinesJAMA, 1967
- Altered Reactivity to Measles VirusJAMA, 1967